381 related articles for article (PubMed ID: 26187429)
1. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
[TBL] [Abstract][Full Text] [Related]
2. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
4. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
5. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
[TBL] [Abstract][Full Text] [Related]
8. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.
Sano T; Shimada K; Sakamoto Y; Yamamoto J; Yamasaki S; Kosuge T
Ann Surg; 2006 Aug; 244(2):240-7. PubMed ID: 16858186
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.
Asakura R; Yanagimoto H; Ajiki T; Tsugawa D; Mizumoto T; So S; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Kuramitsu K; Goto T; Asari S; Kido M; Toyama H; Fukumoto T
Dig Surg; 2022; 39(2-3):65-74. PubMed ID: 35051946
[TBL] [Abstract][Full Text] [Related]
10. A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma.
Yoh T; Seo S; Hatano E; Taura K; Fuji H; Ikeno Y; Okuda Y; Yasuchika K; Kaido T; Okajima H; Uemoto S
Ann Surg Oncol; 2017 May; 24(5):1351-1357. PubMed ID: 28108828
[TBL] [Abstract][Full Text] [Related]
11. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
[TBL] [Abstract][Full Text] [Related]
12. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
13. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma.
Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
17. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
[TBL] [Abstract][Full Text] [Related]
18. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
19. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.
Nagino M
J Gastroenterol; 2012 Nov; 47(11):1165-76. PubMed ID: 22847554
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
